Home Uncategorized Regulatory Aspects of Pharmaceuticals’ Exports in Gulf Cooperation Council Countries

Regulatory Aspects of Pharmaceuticals’ Exports in Gulf Cooperation Council Countries

by admin

Published on:
Journal of Young Pharmacists, 2011; 3(2):155-162
Pharmaceutical Marketing and Management | doi:10.4103/0975-1483.80305
Authors:

Pateriya S, Janodia MD1, Deshpande PB1, Ligade VS1, Talole KB1, Kulshrestha T2, Kamariya Y2, Musmade PB1, Udupa N1

Department of Advanced Pharmaceutical Studies, Manipal University, Manipal-576104,

1Manipal College of Pharmaceutical Sciences, Manipal University, Manipal-576104,

2Zydus Research Center, Ahmedabad, India.

Abstract:

The Gulf cooperation council (GCC) region is considered as “Emerging market” for pharmaceutical export and bilateral trade. The understanding of the regulatory requirements of this region can be beneficial for pharmaceutical export. Some incidents of the year 2008-09, like recession or economic slowdown in highly well-off and regulated market of the EU and US, raised the demand for alternate destinations for business. The regulations of Gulf countries are encouraging the import of quality generic products, which can be good news to the Indian drug manufacturers.

Key words: Exports, Gulf cooperation council, pharmaceutical, regulatory.